Skip to content

Dr. Linders

Active Private limited companyfounded 2022active for 4 yearsDoornelei 7, 2018 AntwerpKBO/BCE: BE 0792.904.625

Annual accounts 2025

micro format, filed on 25-06-2026, 36 days before the deadline
€85,523
▲ 68.8%
€37,654
▼ 16.7%
€23,945
▼ 28.1%
-€18,703
▼ €43,946
15.1%
▼ 40.9 percentage points
0.71
▼ 1.13

Turnover is estimated at about €190,000, probably between €140,000 and €240,000. The micro format does not state turnover.

Balance sheet

balance sheet total €425,837 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

15.1%

Higher than 17% of the 21,373 companies filing micro accounts in human health (NACE 86) in 2025.

0.71

Higher than 10% of the 20,922 companies filing micro accounts in human health (NACE 86) in 2025.

5.6%

Higher than 16% of the 21,223 companies filing micro accounts in human health (NACE 86) in 2025.

Dr. Linders Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: bottom quarter

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202314 months
55,54850,26512,551
41,83938,3528,755
381,6318,98717,100
6,045-1,221-
-18,70325,243-5,845
15.1%56.0%16.2%
0.711.840.84
0.321.050.29
5.630.795.19
37.3%82.6%64.4%
5.6%46.2%10.4%
5.5319.3410.51

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202314 months
Balance sheet: assets
20/58 425,83772,03643,517
21/28 380,53016,79412,876
21 3,545--
22/27 376,98516,79412,876
22 341,8496,213-
23 25,6491,887-
24 8,4647,30111,114
26 1,0221,3921,762
29/58 45,30755,24230,642
3 24,62023,72220,190
30/36 24,62023,72220,190
40/41 4,05224,3113,595
40 4,05222,7503,595
41 -1,561-
50/53 4,000--
54/58 11,4395,3936,614
490/1 1,1971,816243
Balance sheet: equity and liabilities
10/49 425,83772,03643,517
10/15 64,25940,3147,031
10/11 2,5002,5002,500
14 61,75937,8144,531
17/49 361,57831,72236,486
17 296,352--
170/4 296,352--
42/48 64,00929,99936,486
42 26,892--
44 7,0886,3172,414
440/4 7,0886,3172,414
45 10,0439,3015,489
450/3 10,0439,3015,489
47/48 19,98514,38128,583
492/3 1,2171,723-
Income statement
9900 85,52350,67814,729
630 17,8945,0694,224
640/8 29,9744132,178
9901 37,65445,1968,326
75/76B -1467
75 -1467
65/66B 10,0382,5991,195
65 10,0382,5991,195
9903 27,61642,7447,139
67/77 3,6719,4612,608
9904 23,94533,2834,531
9905 23,94533,2834,531
Appropriation of the result
9906 61,75937,8144,531
14P 37,8144,531-
Document PDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 25-06-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 25-06-2026 2026-00198979 PDF
31-12-2024 micro format 31-07-2025 2025-00350002 PDF
31-12-2023 micro format 21-07-2024 2024-00269468 PDF

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets€377,816€8,987€17,100
Intangible fixed assets€3,815--
€17,894€5,069€4,224

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on Dr. Linders

The operating result for 2025 is 17% lower than in 2024.

Debt's share of the balance-sheet total rises from 44.0% to 84.9%. Equity and debt are higher.

Next steps